Iceni Therapeutics is a new Cambridge spin-out company created to explore the commercial development of IP from the Gurdon Institute in Cambridge.
The underlying technology involves modification of the activity of non-coding RNA by targeting RNA modifying enzymes with small molecules. This is an exciting new area of cancer biology relevant to oncology but potentially with broader application.
Tony was pretty clear what he wanted the logo to achieve, so I had a really good brief. It’s a great logo, simply describing the modifying action of the molecule on RNA.
It’s really exciting for me to be involved with projects that have such a great potential to make a real difference for us all.